06 February 2023

Corporate News: Mobility Directive soon to be transposed in Germany and Luxembourg

The Mobility Directive EU 2019/2121 aims to harmonize cross-border conversions and amends the regime applicable to cross-border mergers and divisions. Its transposition was due on 31 January 2023. Germany and Luxembourg are currently in the final stages of adopting the relevant national laws.

As of 2023, companies envisaging corporate restructurings should prepare for a new regime applicable to mergers, migrations and conversions. While Luxembourg will apply the changes proposed by the Mobility Directive only to cross-border restructurings in scope, Germany has opted to extend its reform also to national conversions.

The GSK Update provides an detailed overview of the Mobility Directive.


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
Contact person

Anna Lindner

Local Partner

+352 271802-43


Andrea Carraretto, LL.M.

Senior Associate

+352 271802-42


© GSK Stockmann 2024